Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ATHA is expected to report earnings to fall 92.78% to -12 cents per share on November 06
Q3'25
Est.
$-0.13
Q2'25
Missed
by $1.58
Q1'25
Missed
by $0.05
Q4'24
Est.
$-0.38
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -179 cents, missing the estimate of -21 cents. With 15.19K shares outstanding, the current market capitalization sits at 16.60M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATHA showed earnings on August 07, 2025. You can read more about the earnings report here.